The Mercer University School of Medicine is conducting a research study, free to those who are chosen to participate, to slow down or possibly reverse the progression of Parkinson’s Disease Dementia and Lewy Body Dementia. To qualify for the free study, the patient must have a sleep disturbance and either Parkinson’s Disease Dementia or Lewy Body Dementia. In addition to no cost for participants in the study, the patients will receive free medical evaluations and medication.
“Currently, there are no treatments available to slow or reverse the inexorable progression of Parkinson’s Disease Dementia and Lewy Body Dementia, diseases which affect about 750 Middle Georgians” said Edward C. Lauterbach, MD, FANPA, DFAPA, Director of the Mercer Neurodegenerative Disease Program. “It’s as though we have been treating headaches caused by a brain tumor with aspirin, rather than treating the tumor causing the headache.”
“Fortunately, our knowledge of the underlying biological processes that drive these illnesses is leading to therapeutic strategies that work in test tubes, but now need to be applied in our patients,” Lauterbach said. “We are finally on the cusp of developing treatments that will actually reverse the disease process rather than just treating its symptoms. Without such treatments, population demographics alone will push the prevalence of these two diseases to affect 2,250 Middle Georgians by the year 2050.”
The Mercer study seeks to establish a slowing or reversal of disease progression and document improvements in cognitive impairments, confusional episodes, functional disability, and other disorders including insomnia, sleepiness, sleep-related behaviors, hallucinations, depression and anxiety.
To be considered for the study, call Mercer University at (478) 301-2107.
To read the complete story concerning the study, click here.